Anika Therapeutics
ANIK
146 hedge funds and large institutions have $336M invested in Anika Therapeutics in 2013 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 48 increasing their positions, 42 reducing their positions, and 9 closing their positions.
389% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 9
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
70% more capital invested
Capital invested by funds: $197M → $336M (+$139M)
45% more call options, than puts
Call options by funds: $3.6M | Put options by funds: $2.48M
32% more funds holding
Funds holding: 111 → 146 (+35)
14% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 42
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$9.87M |
| 2 |
AAM
AMI Asset Management
Los Angeles,
California
|
+$4.88M |
| 3 |
QBFM
QS Batterymarch Financial Management
New York
|
+$3.22M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$3.11M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$5.42M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.96M |
| 3 |
PA
Perceptive Advisors
New York
|
-$3.44M |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$3.13M |
| 5 |
Two Sigma Investments
New York
|
-$3.11M |
ANIK Hedge Fund Activity: Q4 2013 in Review
146 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q4 2013, worth a combined $336M — up 70% from $197M a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new ANIK positions and 9 closed out — a net gain of 35 holders — while 48 added to existing stakes and 42 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $9.87M. The largest seller was TFS Capital, cutting an estimated $5.42M.
- 146 institutional investors held Anika Therapeutics (ANIK) as of Q4 2013, up from 111 in Q3 2013.
- Funds reported $336M of Anika Therapeutics stock for Q4 2013, up 70% quarter-over-quarter.
- 44 funds opened new Anika Therapeutics positions in Q4 2013 and 9 closed out, a net change of +35 holders.
- The largest Anika Therapeutics buyer in Q4 2013 was BlackRock Fund Advisors, an estimated $9.87M added.
- The largest Anika Therapeutics seller in Q4 2013 was TFS Capital, an estimated $5.42M sold.
Based on aggregated 13F filings for Q4 2013.